IP Verse

Use Of Anti-Vegf Antibody In Combination With Chemotherapy For Treating Breast Cancer

Patent No. EP2361085 (titled "Use Of Anti-Vegf Antibody In Combination With Chemotherapy For Treating Breast Cancer") was filed by F Hoffmann LA Roche on Nov 20, 2009. The application was issued on Jan 2, 2019.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERNov 25, 2015VICKERS
GLASNov 25, 2015GLAS
CABINET BEAU DE LOMENIENov 23, 2015MARRO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP2361085

F HOFFMANN LA ROCHE
Application Number
EP09764134A
Filing Date
Nov 20, 2009
Status
Patent Maintained As Amended
Jun 15, 2018
Publication Date
Jan 2, 2019
External Links
Slate, Register , Google Patents